Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

about

Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

Item

http://www.wikidata.org/entity/Q38378765

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

@en

type

Item

label

Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

@en

prefLabel

Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

@en

P1476

Effect of accurate heart delineation on cardiac dose during the CONVERT trial.

@en

P2093

Elena Wilson

http://www.w3.org/2001/XMLSchema#string

Nicki Groom

http://www.w3.org/2001/XMLSchema#string

P2860

Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.

Heart irradiation as a risk factor for radiation pneumonitis.

Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer.

Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer

Radiation as a risk factor for cardiovascular disease.

Risk of valvular heart disease after treatment for Hodgkin lymphoma

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer.

Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with lim

Hodgkin's lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms.

P304

20170036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1259/BJR.20170036

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1073

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Corinne Faivre-Finn

P577

2017-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28362511

http://www.w3.org/2001/XMLSchema#string

P932

5605115

http://www.w3.org/2001/XMLSchema#string